| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $250.4M | $264.3M | $286.0M |
| YoY Revenue Growth % | -5.2% | -7.6% | — |
| Gross Profit | $83.0M | $92.6M | — |
| Gross Margin % | 33.1% | 35.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$59.7M | -$70.4M | -$21.1M |
| Operating Margin % | -23.8% | -26.6% | -7.4% |
| Net Income (GAAP) | -$46.6K | -$88.4K | -$15.8K |
| EBITDA (Normalized) | -$55.6M | -$65.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$4.7M | -$7.3M | $31.9M |
| Capital Expenditures (CapEx) | $5.2M | $6.7M | — |
| Free Cash Flow (FCF) | -$9.9M | -$14.0M | $31.9M |
| FCF Margin % | -4.0% | -5.3% | 11.2% |
| Return on Invested Capital (ROIC %) | -29.5% | -29.6% | — |
| Cash & Short-Term Equivalents | $36.7M | $45.4M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $196.4M | $233.1M | — |